| __timestamp | Dr. Reddy's Laboratories Limited | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 79838000 |
| Thursday, January 1, 2015 | 62786000000 | 121816000 |
| Friday, January 1, 2016 | 62427000000 | 117633000 |
| Sunday, January 1, 2017 | 62453000000 | 4577000 |
| Monday, January 1, 2018 | 65724000000 | 12670000 |
| Tuesday, January 1, 2019 | 70421000000 | 12135000 |
| Wednesday, January 1, 2020 | 80591000000 | 18942000 |
| Friday, January 1, 2021 | 86645000000 | 32328000 |
| Saturday, January 1, 2022 | 100551000000 | 44678000 |
| Sunday, January 1, 2023 | 42907000000 | 65486000 |
| Monday, January 1, 2024 | 115557000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, understanding cost efficiency is crucial. Dr. Reddy's Laboratories Limited and PTC Therapeutics, Inc. offer a fascinating comparison. From 2014 to 2023, Dr. Reddy's consistently maintained a robust cost of revenue, peaking in 2024 with a 115% increase from its 2014 figures. In contrast, PTC Therapeutics, Inc. showed a more volatile pattern, with costs fluctuating significantly, peaking in 2015 and then experiencing a notable dip in 2017. By 2023, PTC's cost of revenue had increased by approximately 720% from 2014, yet it remains a fraction of Dr. Reddy's. This disparity highlights Dr. Reddy's superior efficiency in managing production costs, a critical factor in its competitive edge. As the industry faces new challenges, these insights into cost management strategies are invaluable for stakeholders and investors alike.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Biogen Inc. vs PTC Therapeutics, Inc.
Analyzing Cost of Revenue: Neurocrine Biosciences, Inc. and PTC Therapeutics, Inc.
Cost Insights: Breaking Down Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.'s Expenses
Selling, General, and Administrative Costs: Dr. Reddy's Laboratories Limited vs PTC Therapeutics, Inc.
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Iovance Biotherapeutics, Inc.
Cost of Revenue: Key Insights for Exelixis, Inc. and PTC Therapeutics, Inc.
Cost of Revenue Comparison: Telix Pharmaceuticals Limited vs PTC Therapeutics, Inc.
Analyzing Cost of Revenue: PTC Therapeutics, Inc. and ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: PTC Therapeutics, Inc. vs Ligand Pharmaceuticals Incorporated
Analyzing Cost of Revenue: PTC Therapeutics, Inc. and MiMedx Group, Inc.